First Time Loading...

Charles River Laboratories International Inc
NYSE:CRL

Watchlist Manager
Charles River Laboratories International Inc Logo
Charles River Laboratories International Inc
NYSE:CRL
Watchlist
Price: 228.41 USD 0.13% Market Closed
Updated: May 14, 2024

Net Margin
Charles River Laboratories International Inc

10.7%
Current
12%
Average
1.1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
10.7%
=
Net Income
438.8m
/
Revenue
4.1B

Net Margin Across Competitors

Country Company Market Cap Net
Margin
US
Charles River Laboratories International Inc
NYSE:CRL
11.8B USD
11%
US
Thermo Fisher Scientific Inc
NYSE:TMO
228.4B USD
14%
US
Danaher Corp
NYSE:DHR
186.3B USD
18%
US
Agilent Technologies Inc
NYSE:A
43.3B USD
18%
US
IQVIA Holdings Inc
NYSE:IQV
41.6B USD
9%
CH
Lonza Group AG
SIX:LONN
37.2B CHF
10%
KR
Samsung Biologics Co Ltd
KRX:207940
55.6T KRW
23%
US
Mettler-Toledo International Inc
NYSE:MTD
31.2B USD
21%
US
West Pharmaceutical Services Inc
NYSE:WST
26.1B USD
19%
IE
ICON PLC
NASDAQ:ICLR
25.6B USD
8%
US
Waters Corp
NYSE:WAT
20.7B USD
21%
Charles River Laboratories International Inc
NYSE:CRL
Country US
Market Cap 11.8B USD
Net Margin
11%
Thermo Fisher Scientific Inc
NYSE:TMO
Country US
Market Cap 228.4B USD
Net Margin
14%
Danaher Corp
NYSE:DHR
Country US
Market Cap 186.3B USD
Net Margin
18%
Agilent Technologies Inc
NYSE:A
Country US
Market Cap 43.3B USD
Net Margin
18%
IQVIA Holdings Inc
NYSE:IQV
Country US
Market Cap 41.6B USD
Net Margin
9%
Lonza Group AG
SIX:LONN
Country CH
Market Cap 37.2B CHF
Net Margin
10%
Samsung Biologics Co Ltd
KRX:207940
Country KR
Market Cap 55.6T KRW
Net Margin
23%
Mettler-Toledo International Inc
NYSE:MTD
Country US
Market Cap 31.2B USD
Net Margin
21%
West Pharmaceutical Services Inc
NYSE:WST
Country US
Market Cap 26.1B USD
Net Margin
19%
ICON PLC
NASDAQ:ICLR
Country IE
Market Cap 25.6B USD
Net Margin
8%
Waters Corp
NYSE:WAT
Country US
Market Cap 20.7B USD
Net Margin
21%

Profitability Report

View the profitability report to see the full profitability analysis for Charles River Laboratories International Inc.

Full Profitability Report

See Also

Summary
CRL intrinsic value, competitors valuation, and company profile.
DCF Valuation
CRL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CRL stock valuation using valuation multiples.
Wall Street Estimates
CRL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CRL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
10.7%
=
Net Income
438.8m
/
Revenue
4.1B
What is the Net Margin of Charles River Laboratories International Inc?

Based on Charles River Laboratories International Inc's most recent financial statements, the company has Net Margin of 10.7%.

ALPHA SPREAD
Join more than 137,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.